Molecule
Terconazole is an azole antifungal indicated for the treatment of vulvovaginal candidiasis in adult females. It is available as vaginal cream and vaginal suppositories. MedsAcross supplies Terconazole for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
From the regulator-approved product information. Each section names its source.
Terconazole Vaginal Cream, is indicated for the treatment of vulvovaginal candidiasis in adult females. Terconazole Vaginal Cream is an azole antifungal indicated for the treatment of vulvovaginal candidiasis in adult females.
Source: US FDA prescribing information
Terconazole is an antifungal agent.
Source: US FDA prescribing information
The recommended dose is one applicator full of Terconazole Vaginal Cream (5 grams of cream containing 40 mg terconazole) administered intravaginally once daily at bedtime for three consecutive days. Terconazole Vaginal Cream is not for oral or ophthalmic use. • One full applicator (5 grams) of Terconazole Vaginal Cream administered intravaginally once daily at bedtime for three consecutive days. • Not for oral or ophthalmic use.
Source: US FDA prescribing information
Terconazole Vaginal Cream, 0.8% is contraindicated in patients with known hypersensitivity to terconazole or to any of the components of the cream. Known hypersensitivity to terconazole or any other component of the cream
Source: US FDA prescribing information
Risk of Skin Irritation and Flu-Like Symptoms: Discontinue Terconazole Vaginal Cream and do not retreat if skin irritation, fever, chills or flu-like symptoms are reported during use.
Source: US FDA prescribing information
Most common adverse reactions (incidence ≥ 2%) were headache, dysmenorrhea, genital burning and itching, and abdominal pain.
Source: US FDA prescribing information
Oral Contraceptives: There is no known interaction with the concomitant use of this product and oral contraceptives.
Source: US FDA prescribing information
Store at 20°C to 25°C (68°F to 77°F), excursions permitted 15°C to 30°C (59°F to 86°F).
Source: US FDA prescribing information
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
4 presentations of Terconazole, sorted by availability.
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Terconazole 0.4% vaginal creamVaginalGeneric name | — | US FDA | Available on request |
| Terconazole 0.8% vaginal creamVaginalGeneric name | — | US FDA | Available on request |
| Terconazole 80 mg vaginal suppositoryVaginalGeneric name | — | US FDA | Available on request |
| Terconazole Vaginal Cream 0.8% 0.8% vaginal creamVaginal | E. Fougera | US FDA | Available on request |
1 brand names across 1 markets.
United States
Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.
| Register | Status | Source |
|---|---|---|
| US FDA | First approved 31 December 1987 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Conditions linked to Terconazole in public data. This is not a list of approved uses, see the clinical information.
Yes, on request. MedsAcross lists 4 presentations of Terconazole and sources them for licensed hospitals, importers and physicians against valid import documents.
The catalogue lists 1 brand names for Terconazole, including Terconazole Vaginal Cream 0.8%.
Yes. The US FDA first approved Terconazole on 31 December 1987, according to Drugs@FDA.
No listed presentation of Terconazole is recorded as needing a cold chain. Storage conditions are shown on each presentation page.
Terconazole is classified under ATC code G01AG02 (Terconazole).
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.